Antimicrobial Stewardship in Everyday Practice (Fellows)
Content in this section is available through 5 case-based eLearning scenarios. These include:
- AS in Everyday Practice: A Clinic Visit Case
- AS in Everyday Practice: The Antibiotic Approval Request Case
- AS in Everyday Practice: The Curbside Call Case
- AS in Everyday Practice: The Prospective Audit and Feedback Case
- AS in Everyday Practice: The Rapid Diagnostic Dilemma Case
The cases are based on common ID clinical scenarios and highlight specific AS practices in routine clinical care. Each of the 5 cases has formative questions embedded in the case, suggestions for applying concepts to the your institution, and a “clinical pearls” pocket card for reference. You are encouraged to complete at least 3 AS debriefing activities with your supervising faculty during routine patient care.
Target Audience
Fellows/Trainees in Antimicrobial Stewardship Training Program
Learning Objectives
Upon completion of this section, you will be able to:
- Judge when to recommend formal ID consultation or AS intervention
- Recognize the major “infectious diseases syndromes” where antimicrobials are over- and misused in acute care inpatient and outpatient settings, and thestewardship techniques to improve prescribing for these infections
- Identify common process and outcome measures/metrics
- Compare and contrast effective AS techniques in the inpatient vs. outpatient settings
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
Name | Individual's Role in Activity | Name of Commercial Interest | Nature of Relationship |
---|---|---|---|
Abbo, Lillian | Workgroup member | Pfizer Brazil | Honoraria |
Advani, Sonali | Workgroup member | Nabriva Therapeutics | Advisory/Consultant Role |
Amstrong, Wendy | Workgroup member | None | |
Barsoumian, Alice | Workgroup member | None | |
Beeler, Cole | Workgroup member | None | |
Bystritsky, Rachel | Workgroup member | None | |
Cherabuddi, Kartik | Workgroup member | Gatorade | Start - up Research Fund |
NIH (Medimmune) | Research Grant | ||
Cohen, Seth | Workgroup member | None | |
Hamilton, Keith | Workgroup member | None | |
Ince, Dilek | Workgroup member | Ansun Pharma | Research Grant |
Justo, Julie Ann | Workgroup member | None | |
Logan, Ashleigh | Staff | None | |
Luther, Vera | Workgroup member | None | |
Lynch, John | Workgroup member | Astellas Pharmaceuticals, Juno Therapeutics | Advisory/Consultant Role |
Nori, Priya | Workgroup member | None | |
Ohl, Christopher | Workgroup member | Paratek, Bayer, Cempra Pharmaceuticals | Advisory/Consultant Role |
Patel, Payal | Workgroup member | None | |
Pottinger, Paul | Workgroup member | McGraw Hill, Elsevier | Honoraria |
Schwartz, Brian | Workgroup member | None | |
Spicer, Jennifer | Workgroup member | None | |
Stack, Conor | Workgroup member | None | |
Zhou, Yuan | Workgroup member | None | |
Shnekendorf, Rachel | Staff | None |